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  Abstract	  
The	  aryl	  hydrocarbon	  receptor	  (AHR),	  a	  ligand-­‐ac:vated	  transcrip:on	  factor,	  
mediates	  an	  excep:onal	  range	  of	  biological	  effects,	  from	  embryonic	  development	  
and	  immune	  response	  to	  xenobio:c	  toxicity.	  However,	  the	  molecular	  mechanisms	  
by	  which	  AHR	  affects	  this	  diverse	  set	  of	  processes	  are	  not	  well	  understood.	  The	  
African	  clawed	  frog	  (X.	  laevis)	  serves	  as	  a	  novel	  model	  organism	  in	  which	  to	  study	  
AHR	  func:ons	  due	  to	  its	  possession	  of	  paralogous	  AHR	  genes.	  While	  humans	  and	  
most	  mammals	  possess	  only	  a	  single	  gene	  that	  codes	  for	  AHR,	  X.	  laevis	  possesses	  
two	  paralogous	  AHR	  genes,	  AHR1α	  and	  AHR1β,	  that	  arose	  from	  a	  whole	  genome	  
duplica:on	  event	  ~40	  million	  years	  ago.	  The	  reten:on	  of	  duplicated	  genes	  
commonly	  results	  from	  func:onal	  or	  regulatory	  divergence	  between	  the	  two	  
copies	  of	  the	  progenitor	  gene,	  and	  we	  predict	  that	  AHR1α	  and	  AHR1β	  possess	  
dis:nct,	  yet	  overlapping	  func:ons.	  To	  develop	  a	  route	  for	  inves:ga:ng	  the	  
func:ons	  of	  each	  AHR	  paralog,	  we	  employed	  transcrip:on	  ac:vator-­‐like	  effector	  
nucleases	  (TALENs)	  to	  generate	  AHR-­‐paralog-­‐specific	  knockouts	  in	  XTC-­‐2	  cells,	  a	  
cell	  line	  derived	  from	  X.	  laevis	  tadpole	  :ssue.	  We	  have	  generated	  mul:ple	  cell	  
lines	  possessing	  21,	  11,	  and	  9	  base	  pair	  dele:ons	  in	  the	  AHR1β	  gene	  and	  currently	  
seek	  cell	  lines	  possessing	  muta:ons	  in	  the	  AHR1α	  gene	  and	  both	  AHR	  genes	  
simultaneously.	  Once	  we	  generate	  cell	  lines	  homozygous	  for	  paralog-­‐specific	  AHR	  
knockouts,	  we	  will	  employ	  qPCR	  to	  measure	  the	  consequen:al	  transcrip:onal	  
response	  of	  each	  paralog	  knockout	  to	  determine	  the	  poten:al	  func:ons	  of	  
AHR1α	  and	  AHR1β.	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  TALEN	  Mechanism	  and	  Background	  
-­‐AHR1α	  and	  AHR1β	  share	  86%	  
amino	  acid	  iden:ty.	  
	  
-­‐AHR1α	  and	  AHR1β	  are	  expressed	  at	  
different	  levels	  between	  dis:nct	  
organs	  and	  cells.	  (Lavine	  2005)	  
	  
-­‐AHR	  is	  ligand	  ac:vated	  to	  modulate	  
the	  classical	  target	  gene,	  
cytochrome	  P450	  1A6	  (CYP1A6).	  
(Figure	  1)	  
	  
-­‐Characteriza:on	  of	  paralog-­‐specific	  
AHR	  knockouts	  in	  the	  XLK-­‐WG	  cell	  
line	  (X.	  Laevis	  kidney)	  revealed	  that	  
both	  gene	  products	  contribute	  to	  
CYP1A6	  induc:on	  by	  2,3,7,8	  
tetrachlorodibenzo-­‐p-­‐dioxin	  (TCDD),	  
a	  xenobio:c	  agonist.	  (SHF,	  Figure	  2)	  
	  
-­‐Paralog-­‐specific	  AHR	  ac:vity	  in	  the	  
XTC-­‐2	  cell	  line	  derived	  from	  X.	  laevis	  
tadpole	  tail	  cells	  may	  prove	  a	  more	  
relevant	  developmental	  model.	  
	  
Figure	  1:	  Classical	  AHR	  pathway.	  Inac:vated	  
cytoplasmic	  AHR	  is	  bound	  by	  a	  ligand	  and	  transported	  
into	  the	  nucleus	  where	  ac:ve	  AHR	  heterodimerizes	  
with	  ARNT.	  The	  AHR-­‐ARNT	  complex	  binds	  dioxin	  
response	  elements	  and	  modulates	  the	  transcrip:on	  
of	  AHR-­‐dependent	  genes.	  	  	  
Figure	  3:	  A)	  A	  representa:on	  of	  the	  TALEN	  
mechanism	  is	  shown.	  TALENs	  bind	  specific	  DNA	  
sequences	  and	  the	  C-­‐terminal	  FokI	  nuclease	  cleaves	  
the	  DNA	  genera:ng	  a	  double	  stand	  break.	  B)	  The	  
repair	  of	  the	  double	  strand	  break	  through	  non-­‐
homologous	  end	  joining	  can	  generate	  muta:ons.	  
Figure	  2:	  Mutant	  
Characteriza&on.	  
Rela:ve	  expression	  of	  
CYP1A6	  in	  XLK-­‐WG	  
cells,	  the	  A3	  cell	  line	  
(XLK-­‐WG,	  AHR1α-­‐/-­‐)	  
and	  the	  B1	  cell	  line	  
(XLK-­‐WG,	  AHR1β-­‐/-­‐)	  
treated	  with	  100	  nm	  
of	  TCDD	  
Transfec:on	  Op:miza:on	  and	  Efficiency	  
-­‐Transcrip:on	  ac:vator-­‐like	  effector	  
nucleases	  (TALENs)	  have	  been	  
employed	  to	  modify	  targeted	  
endogenous	  genes	  with	  minimal	  off	  
target	  effects	  in	  a	  diverse	  range	  of	  
animals	  and	  cultured	  cells.	  
	  
-­‐TALENs	  provide	  the	  gene	  targe:ng	  
specificity	  necessary	  to	  generate	  
muta:ons	  in	  only	  a	  single	  AHR	  paralog	  
despite	  85%	  shared	  nucleo:de	  iden:ty	  
between	  the	  two	  paralogs.	  	  
	  
-­‐We	  employed	  TALENs	  to	  generate	  
indels	  in	  AHR	  paralogs	  in	  the	  hopes	  of	  
genera:ng	  a	  frameshil	  muta:on	  







Figure	  4:	  TALEN	  constructs.	  Three	  TALEN	  pairs	  have	  
been	  employed	  in	  an	  amempt	  to	  edit	  the	  X.	  laevis	  
genome:	  a	  TALEN	  pair	  to	  generate	  AHR1α	  knockout,	  
a	  TALEN	  pair	  to	  generate	  AHR1β	  knockout,	  and	  and	  a	  
TALEN	  pair	  knockout	  both	  genes.	  TALEN	  constructs	  
were	  designed	  by	  Cellec:s	  Bioresearch	  (Paris,	  
France)	  to	  target	  the	  desired	  AHR	  paralog	  early	  in	  
exon	  2.	  	  
Figure	  5:	  Role	  of	  green	  fluorescent	  protein	  reporter	  gene.	  1.	  XTC-­‐2	  cells	  are	  
trypsinized	  and	  brought	  into	  a	  suspension.	  2.	  XTC-­‐2	  cells	  are	  transfected	  with	  TALEN	  
plasmids	  and	  GFP	  by	  electropora:on	  by	  the	  nucleofector	  4D	  (Lonza)	  3.	  Cells	  are	  
clonally	  isolated,	  and	  GFP	  posi:ve	  cells	  are	  iden:fied	  using	  fluorescent	  microscopy	  
(Olympus	  IX-­‐70)	  4.	  Fluorescing	  cell	  are	  allowed	  to	  grow.	  5.	  Clonal	  cell	  lines	  are	  split.	  
Some	  cells	  are	  isolated	  and	  prepared	  for	  DNA	  isola:on.	  DNA	  is	  then	  sequenced	  
(Retrogen)	  and	  analyzed	  for	  poten:al	  muta:ons.	  Remaining	  cells	  are	  lel	  to	  grow	  to	  
preserve	  the	  poten:al	  knockout	  cell	  line.	  	  
Poten:al	  mutant	  1B1.5	  
	  
1B1.5.1          60 CCTGAACACTGAGCTGGAA-----------CCTGCTTCCATTCCAAGAGGAGATAATATC 108!
1B1.5.4          60 CCTGAACACTGAGCTGGAA-----------CCTGCTTCCATTCCAAGAGGAGATAATATC 109!
AHR1b exon 2     60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
!
Poten:al	  mutant	  1B1.6	  
	  
1B1.6.1          60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
1B1.6.3          60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 118!
1B1.6.4          60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
1B1.6.5          60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
1B1.6.7          60 CCTGAACACTGAGCT---------------------TCCATTCCAAGAGGAGATAATATC  98           
1B1.6.8          60 CCTGAACACTGAGCTGGAA-----------CCTGCTTCCATTANAAGAGGAGATAATATC 108!
AHR1b exon 2     60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
	  
Poten:al	  mutant	  1B1.7	  
	  
1B1.7.1          60 CCTGAACACTGAG---------------------CTTCCATTCCAAGAGGAGATAATATC  98!
1B1.7.2          60 CCTGAACACTGAG---------------------CTTCCATTCCAAGAGGAGATAATATC  98!
1B1.7.3          60 CCTGAACACTGAG---------------------CTTCCATTCCAAGAGGAGATAATATC  99!
1B1.7.4          60 CCTGAACACTGAG---------------------CTTCCATTCCAAGAGGAGATAATATC  98!
AHR1b exon 2     60 CCTGAACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATA 117!
	  
	  
1B1.5	  Protein	  Alignment	  
	  
1B15.1 1 IKPTQAESVKSNPSKRHRDRLNTE---------LEPASIPRGDNIKTQVFRAYTHCLFGG 51!
1B15.2 1 IKPTQAESVKSNPSKRHRDRLNTE---------LEPASIPRGDNIKTQAFRA-TQCLFKG 50!
!
1B1.6	  Protein	  Alignment	  	  
	  
1B1.6.1          1 IKPTQAESVKSNPSKRHRDRLNTELERLASLLPFQEEIISKLDKLSVLRLSV---SYLRA 57!
1B1.6.3          1 IKPTQAESVKSNPSKRHRDRLNTELERLASLLPFQEEIISKLDKLSVLRLSV---SYLRA 57!
1B1.6.4          1 IKPTQAESVKSNPSKRHRDRLNTELERLASLLPFQEEIISKLDKLSVLRLSV---SYLRA 57!
1B1.6.5          1 IKPTQAESVKSNPSKRHRDRLNTELERLASLLPFQEEIISKLDKLSVLRLSV---SYLRA 57            
1B1.6.7          1 IXPTQAERVKPNPSNRPTDRLNTE-------LPFQEEIISELDKLSELXLSG---XYLRA 50         !
1B1.6.8          1 IKPTQAESVKSNPSKRHRDRLNTE---------LEPASIXRGDNIKTQVLRAXTHCLFRG 51 !
	  
1B1.7	  Protein	  Alignment	  	  
	  
1B1.7.1          1 IKPTQAESVKSNPSKRHRDRLNTE-------LPFQEEIISXLDKLSVLILGV---SYLRA 50!
1B1.7.3          1 IKPTQAESVKSNPSKRHIDRLNTE-------LPFQEEIISKLDKLSVLRLSV---SYLRA 50!
1B1.7.4          1 IKPTQAESVKSNPSKRHRDRLNTE-------LPFQEEIISKLDKLSVLRLSV---SYLRA 50!






Figure	  8:	  Summary	  of	  current	  standing	  and	  workflow	  of	  future	  work.	  While	  poten:al	  AHR1β	  
knockouts	  have	  been	  generated,	  further	  sequencing	  analysis	  must	  be	  performed	  to	  confirm	  
homozygosity	  of	  the	  muta:on.	  Homozygous	  complete	  AHR1	  knockout	  and	  homozygous	  AHR1α	  
knockout	  cells	  lines	  will	  also	  be	  generated.	  The	  transcrip:onal	  consequence	  of	  each	  muta:ons	  will	  
be	  characterized.	  Results	  will	  be	  analyzed	  for	  func:onal	  dis:nc:ons	  between	  different	  muta:ons	  and	  
between	  the	  muta:ons	  and	  the	  wild	  type.	  The	  findings	  will	  also	  be	  compared	  to	  characteriza:on	  
results	  from	  XLK-­‐WG	  cells	  to	  determine	  the	  presence	  of	  dis:nct	  ac:vity	  between	  cell	  types.	  	  
Figure	  7:	  Candidate	  AHR1β	  mutant	  cell	  lines.	  The	  cell	  lines	  1B1.5,	  1B1.6,	  and	  1B1.7	  generated	  from	  
wild	  type	  XTC-­‐2	  cells	  are	  promising	  for	  the	  possession	  of	  a	  homozygous	  AHR1β	  knockout.	  1B1.6	  
contains	  some	  wild	  type	  cell	  contamina:on	  that	  may	  be	  resolved	  by	  a	  clonal	  dilu:on	  of	  the	  cell	  line.	  
However,	  1B1.6	  may	  be	  possess	  a	  heterozygous	  muta:on	  and	  require	  further	  gene-­‐edi:ng.	  
Figure	  6:	  XTC-­‐2	  transfec&on	  screen.	  XTC-­‐2	  cell	  were	  examined	  under	  brighoield	  
(lel)	  and	  fluorescent	  light	  (right)	  to	  assess	  transfec:on	  efficiency.	  The	  transfec:on	  
efficiency	  was	  calculated	  by	  taking	  the	  ra:o	  of	  cells	  fluorescing	  with	  our	  reporter	  
gene	  to	  the	  total	  number	  of	  cells	  in	  the	  frame.	  
-­‐No	  protocol	  to	  transfect	  XTC-­‐2	  cells	  with	  the	  4D-­‐nucleofector	  previously	  existed.	  
	  
-­‐XTC-­‐2	  cells	  were	  transfected	  with	  16	  dis:nct	  electropora:on	  shocks	  in	  3	  unique	  
transfec:on	  solu:ons.	  
	  
-­‐Transfected	  cells	  were	  counted	  to	  calculate	  the	  ra:o	  of	  cells	  fluorescing	  with	  the	  GFP	  
reporter	  gene	  to	  the	  number	  of	  total	  cells.	  An	  es:mate	  of	  cell	  death	  was	  also	  
calculated.	  
	  
-­‐Op:mized	  transfec:on	  procedure	  ensures	  that	  TALENs	  can	  pass	  into	  XTC-­‐2	  cells	  while	  
minimizing	  cell	  death	  and	  damage.	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xl ahr1a ATGAACACGAACATCATGTACGCCAGCAGGAAGAGGAGAAAACCCGTCCAGAAAACAATT  !
xl ahr1b ATGAACACGAACATCATATACGCCGGCAGGAAGAGGAGAAAACCCGTCCAGAAAATAATT  !
         ***************** ****** ****************************** ****!
                     !
xl ahr1a AAGCCAACCCAGTCTGAAGGTGTCAAGTCCAACCCGTCAAAGAGGCACAGAGATCGGCTC !
xl ahr1b AAGCCAACACAGGCTGAAAGTGTCAAGTCCAACCCATCTAAGAGGCACAGAGATCGCCTG !
         ******** *** ***** **************** ** ***************** ** !
!
xl ahr1a AACACTGAGTTGGACAGATTGGCAAGCCTGCTTCCATTCTCAGACGAGATCATATCAAAA !
xl ahr1b AACACTGAGCTGGAAAGATTGGCAAGCCTGCTTCCATTCCAAGAGGAGATAATATCAAAA !
         ********* **** ************************  *** ***** *********!
!
xl ahr1a CTTGACAAGCTTTCAGTGCTTAGACTCAGTGTTAGTTATTTGAGGGCCAAGGGTTTTTTT !
xl ahr1b CTTGACAAGCTTTCCGTGCTTAGACTCAGTGTTAGCTATTTAAGGGCCAAGGGTTTCTTT !
         ************** ******************** ***** ************** ***!
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